- Report
- May 2026
- 150 Pages
China
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
Spain
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
Turkey
From €4411EUR$4,850USD£3,779GBP
- Report
- May 2026
- 150 Pages
United Kingdom
From €4411EUR$4,850USD£3,779GBP
- Report
- March 2026
- 213 Pages
Canada
From €4411EUR$4,850USD£3,779GBP
- Report
- March 2026
- 218 Pages
China
From €4411EUR$4,850USD£3,779GBP
- Report
- March 2026
- 223 Pages
India
From €4411EUR$4,850USD£3,779GBP
- Report
- March 2026
- 228 Pages
Germany
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
Canada
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
China
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
Germany
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
India
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
Canada
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
China
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 150 Pages
India
From €4411EUR$4,850USD£3,779GBP
- Report
- February 2026
- 153 Pages
Canada
From €4411EUR$4,850USD£3,779GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more